C. Delvincourt et al., RET AND TRK PROTOONCOGENE ACTIVATION IN THYROID PAPILLARY CARCINOMAS IN FRENCH PATIENTS FROM THE CHAMPAGNE-ARDENNE REGION, Clinical biochemistry, 29(3), 1996, pp. 267-271
Objectives: To investigate the presence of ret and trk protooncogene r
earrangements in thyroid tumors. Design and Methods: High-molecular-we
ight DNA was extracted from 36 thyroid tumors (1 multinodular goiter,
14 follicular adenomas, 16 papillary carcinomas, 1 lymph node metastas
is of a papillary carcinoma, 1 follicular carcinoma, and 3 medullary c
arcinomas) and 22 adjacent tissues. Southern blot analysis was perform
ed after digestion with EcoR1 or BamH1, using specific probes for ret
and trk. Results: Only 2 ret rearrangements were found in 2 papillary
carcinomas (overall frequency: 6%; papillary carcinoma frequency: 13%)
. All normal or tumor samples were negative for the presence of a trk
rearrangement. Conclusions: The previous data from the literature are
highly conflicting, ranging from 0 to 30% of activation. Our results c
ould be, therefore, classified as medium between these extreme values.
It seems, therefore, that genetic and/or geographical factors could p
lay a role in ret and trk proto-oncogene activation.